Guide

Tracking a GLP-1 protocol

Last reviewed 2026-06-11 · 5 min read

Bottom line: GLP-1s are weekly, titrated and long-lived in the body. All three properties make memory a bad logbook — and make a written dose history unusually valuable.

Titration means your dose has a history

Semaglutide and tirzepatide protocols typically climb through defined steps (for example 0.25 → 0.5 → 1 → 1.7 → 2.4 mg for semaglutide, or 2.5 → 5 → 7.5 → 10 → 12.5 → 15 mg for tirzepatide) with several weeks at each step. Six months in, "what was I taking in week 9?" is a real question — for you, your clinician, and for making sense of your own weight curve. A log that records the dose at each injection answers it in one glance.

A week is a long time to remember

Daily habits are self-reinforcing; weekly ones aren't. The single most common GLP-1 logging failure is the honest blank: "did I inject last Tuesday or the Tuesday before?" A reminder on the right weekday plus a one-tap "taken" mark closes that gap permanently — and the streak it builds is its own motivation.

Half-life context

Semaglutide's half-life is about a week, tirzepatide's around five days. Practical consequences worth understanding (both are visible on a half-life chart):

Stack draws this curve for you: an "in your system" model from each compound's published half-life, anchored to your actual logged doses. See the semaglutide and tirzepatide library pages for the numbers.

What's worth logging alongside

One place, not five apps

The point of tracking isn't the data, it's the correlations: dose step ↔ weight trend ↔ side effects ↔ adherence. They only line up when they live in the same log. That's the whole design thesis of Stack. Get the app →

Not medical advice. This guide is about logging practices. Dose changes, missed-dose handling and whether a GLP-1 is right for you are decisions for you and your clinician, guided by the official label.